Stock Price
83.05
Daily Change
-0.78%
Yearly
-0.12%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Acadia Pharmaceuticals 21.53 -0.36 -1.64% -56.54%
Acorda Therapeutics 1.71 -0.13 -7.07% -75.22%
Agios Pharmaceuticals 29.23 -1.78 -5.74% -35.67%
Alnylam Pharmaceuticals 127.18 -2.94 -2.26% -17.81%
Alexion Pharmaceuticals 182.50 0 0% 70.54%
Amgen 224.00 1.54 0.69% -9.59%
Arena Pharmaceuticals 89.79 0.16 0.18% 15.86%
Bayer 52.58 1.03 2.00% 3.20%
Biogen 218.94 -0.40 -0.18% -18.27%
Bluebird Bio 7.30 -0.42 -5.44% -83.78%
BioMarin Pharmaceutical 83.05 -0.65 -0.78% -0.12%
Gilead Sciences 67.27 -0.07 -0.10% 4.00%
GW Pharmaceuticals 218.96 0 0% 108.53%
Intercept Pharmaceuticals 14.44 -0.75 -4.84% -60.77%
Incyte Corp 72.26 -1.26 -1.71% -20.83%
Insmed 20.42 -1.03 -4.80% -45.50%
Ionis Pharmaceuticals 30.14 -1.04 -3.31% -50.34%
Moderna Inc 150.03 -4.93 -3.18% -5.97%
Neurocrine Biosciences 72.45 -3.06 -4.05% -35.27%
Puma Biotechnology 2.25 -0.08 -3.22% -80.90%
PTC Therapeutics 38.52 -1.02 -2.56% -31.67%
Ultragenyx Pharmaceutical 64.33 -3.65 -5.36% -54.25%
Regeneron Pharmaceuticals 608.72 2.52 0.42% 20.24%
Roche Holding 354.80 5.70 1.63% 11.91%
Seattle Genetics 122.91 -0.64 -0.52% -24.40%
Sangamo BioSciences 5.52 -0.28 -4.83% -61.10%
Sanofi 51.32 -0.08 -0.16% 8.43%
Sarepta Therapeutics 66.88 -3.36 -4.78% -25.80%
United Therapeutics 195.17 -3.40 -1.71% 18.72%
Vertex Pharmaceuticals 228.22 1.63 0.72% -0.79%
Acceleron Pharma 178.75 -0.93 -0.52% 57.43%

Indexes Price Day Year
NASDAQ 13353 -189.34 -1.40% 0.12%

BioMarin Pharmaceutical
BioMarin Pharmaceutical Inc. is a biotechnology company. The Company develops and commercializes pharmaceuticals for various diseases and medical conditions. As of December 31, 2016, the Company's therapy portfolio consisted of five products, and multiple clinical and pre-clinical product candidates. Its commercial products include Aldurazyme (laronidase) for Mucopolysaccharidosis I (MPS I), Firdapse (amifampridine phosphate) for Lambert Eaton Myasthenic Syndrome (LEMS), Kuvan (sapropterin dihydrochloride) for phenylketonuria (PKU), Naglazyme (galsulfase) for Mucopolysaccharidosis VI (MPS VI) and Vimizim (elosulfase alpha) for Mucopolysaccharidosis IV Type A (MPS IV A). The Company is conducting clinical trials on various product candidates for the treatment of various diseases. Its clinical product candidates include Brineura, pegvaliase, vosoritide, BMN 270 and BMN 250.